Overview of the complement pathways and C3G pathophysiology
Overview of the complement pathways and C3G pathophysiology Speaker: Purva Sharma, MD, FACP November 6th, 2025
▶︎
Iptacopan & Pegcetacoplan: The Newcomers Shaping the Future of Care in C3G
▶︎
2025 USTMA: How the Immune System Triggers CM-TMA: Understanding the Classical Pathway
▶︎
Clinical Case Discussions in C3 Glomerulopathy
▶︎
Introduction to Genomic Biomarkers in Radiation Oncology
▶︎
KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson’s Disease (2025)
▶︎
TMA in Practice: Clinical Case Presentations
▶︎
#3 2025 08 23 Cancer Center Lynch Syndrome Symposium Preventing Cancers in Lynch Syndrome
▶︎
2026 CDG Miniseries | Future of CDG Research | Dr. Hudson Freeze | Episode THIRTEEN
▶︎
06-09-26 AP-SILC ECHO | Blood Clots, Brain Inflammation, and Long COVID
▶︎
IgA-NP: Treatment Standard & Future Perspective - Prof. Jonathan Barratt, Prof. Jai Radhakrishnan
▶︎
Engineering Functionally Improved CAR T cells with a Multi-Cytokine Backpack Platform | REBEL System
▶︎
Rocky Mountain Highlights 2023 I Session I: High Yield Topics in Luminal Gastroenterology
▶︎
Day 2 - Robert D Amato
▶︎
2025 USTMA: Stroke and iTTP: What We Know and What You Can Do
▶︎
Advances in Diagnosis and Treatment of Pediatric Neuroinflammatory Conditions - Mary Karalius, MD
▶︎
2026.06.15 ACVNU Journal Club (Aly Fitzgerald)
▶︎
2025 USTMA: Biosimilars in TMA Care: What They Are and Why You May Be Prescribed One
▶︎
MASLD/MASH (NAFLD/NASH) - New Nomenclature, Risk Stratification, and Therapeutics on the Horizon
▶︎
Mathew Maurer, MD, FACC | Cardiac Amyloidosis
▶︎